A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Sadick Research Group, New York

OptiSkin Medical, New York

Dermatology and Skin Surgery Center, PC, Exton

Dermatology and Skin Cancer Specialists, LLC, Rockville

Advanced Medical Research, Sandy Springs

Skin Care Physicians of Georgia, Macon

Direct Helpers Research Center, Hialeah

Hollywood Dermatology, Hollywood

Ziaderm Research, LLC., North Miami Beach

Miami Dermatology and Laser Research, Miami

Encore Medical Research of Boynton Beach, Boynton Beach

Total Vein and Skin LLC, Boynton Beach

Olympian Clinical Research, Tampa

River Region Dermatology and Laser, Montgomery

Dermatologists of Greater Columbus, Bexley

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

Revival Research Institute - Troy, Troy

Oakland Hills Dermatology, Auburn Hills

The Derm Institute of West Michigan, Caledonia

Dundee Dermatology, West Dundee

MediSearch Clinical Trials, Saint Joseph

Dermatology and Advanced Aesthetics, Lake Charles

Complete Dermatology, Sugar Land

Medical Dermatology Specialists, Phoenix

Dermatology Research Associates, Los Angeles

Wallace Medical Group, Inc., Los Angeles

Axon Clinical Research, Inglewood

Clinical Science Institute, Santa Monica

Cura Clinical Research, Sherman Oaks

Avance Clinical Trials Inc, Laguna Niguel

First OC Dermatology, Fountain Valley

Spokane Dermatology Clinic, Spokane

UConn Health, Farmington

Allcutis Research, Inc., Beverly

Allcutis Research, Inc, Portsmouth

Windsor Dermatology, P.C., East Windsor

Clinical Partners, LLC, Johnston